"sars-cov-2-virus"

Israeli researchers found that a Covid protein can cause the immune system to attack healthy cells, possibly explaining severe and long Covid symptoms. The study also identified enoxaparin as a potential blocker. Meanwhile, a new Omicron subvariant is spreading globally.

Condition refers to set of lingering symptoms affecting varied body parts and persisting well beyond acute Covid infection period, including cough, muscle and joint pain, fatigue, brain fog, difficulty in focusing

The recently published study in Science Translational Medicine elucidates how these effects play a role in long Covid symptoms and identify potential new targets for treatment.

Beijing: Wuhan is back in the news as a team of scientists have warned of a lethal variant called ‘NeoCov’ that requires only one mutation to infiltrate human cells and carries the combination of Middle East Respiratory Syndrome coronavirus (MERS)-CoV mortality rate (where one in every three infected persons may die) and the current SARS-CoV-2 […]

Hyderabad: Amid safety concerns around antiviral drug molnupiravir, the US-based pharma company MSD (Merck is known as MSD outside the US and Canada) came out in defence of its drug developed in collaboration with Ridgeback Biotherapeutics. The company in its statement on Friday, said, “We are confident in the clinical profile of molnupiravir, which demonstrated […]

Washington: Scientists are developing a chewing gum laced with a plant-grown protein that serves as a “trap” for the SARS-CoV-2 virus, which causes COVID-19, reducing viral load in saliva and potentially lowering transmission. The researchers noted that people who are fully vaccinated can still become infected with SARS-CoV-2 and can carry a viral load similar […]

State’s response unique and strategic, say health officials

Indian partner plans to manufacture, test and commercialise the injectable vaccine in the country where the Covid-19 vaccine market is expected to grow to over $2.3 billion by 2027

The test kit can produce results within 30 minutes for both symptomatic and asymptomatic patients.

According to senior doctors in Hyderabad, at some point in the near future, as the protection provided by Covid vaccines wane, there will be demand for booster shots

Public health officials warn public not to get complacent and allow virus to regain foothold

The study, led by researchers from the Indian Institute of Technology, Guwahati, and University of Massachusetts, showed that infection with a specific coronavirus strain reactivated dormant Mycobacterium tuberculosis (MTB) in mice.

Vaccination rate must go up 3-fold to cover 80% of adult population by Sept, given the rapid mutation of the virus

The origins of the COVID-19 remain a widely debated topic, with some scientists and politicians maintaining that the possibility of a lab leak of the deadly virus exists.

It was developed indigenously by scientists, followed by extensive validation on over 1000 patient samples at various COVID hospitals in Delhi.

A team of scientists from Hokkaido University in Japan used a novel antigen-based kit, Lumipulse SARS-CoV-2 Ag kit (Lumipulse), developed by a Japanese company Fujirebio

The B1617 variant was, till now, deemed a 'variant of interest' by the WHO.

Covid-19 drug candidate has been developed by VINS Bioproducts in collaboration with Centre for Cellular and Molecular Biology and University of Hyderabad

Double mutant strains found in 4-5% of samples in Telangana

Large-scale supercomputer simulations at the atomic level showed that the dominant "G form" variant of the Covid-19 causing virus is more infectious partly.